Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort
European Journal of Cancer · 2026-11 · 248 · 117443
DOI: 10.1016/j.ejca.2026.117443 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Masahiro Yamashita und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Mutation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
- Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan. Electronic address: kiichiro_nino@okayama-u.ac.jp.
- Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
- Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan; Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, J…
- Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University, Okayama, Japan; Department of Tumor Microenvironme…
- Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmace…
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yamashita, M., Ninomiya, K., Tomida, S., Nakata, E., Morita, A., Hara, N., Takada, K., Makimoto, G., Kubo, T., Ichihara, E., Ohashi, K., Hotta, K., Togashi, Y., Maeda, Y., & Ennishi, D. (2026). Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort. European Journal of Cancer, 248, 117443. https://doi.org/10.1016/j.ejca.2026.117443
Vancouver
Yamashita M, Ninomiya K, Tomida S, Nakata E, Morita A, Hara N, et al. Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort. European Journal of Cancer. 2026;248:117443. doi:10.1016/j.ejca.2026.117443
BibTeX
@article{Yamashita2026,
author = {Yamashita, Masahiro and Ninomiya, Kiichiro and Tomida, Shuta and Nakata, Eiji and Morita, Ayako and Hara, Naofumi and Takada, Kenji and Makimoto, Go and Kubo, Toshio and Ichihara, Eiki and Ohashi, Kadoaki and Hotta, Katsuyuki and Togashi, Yosuke and Maeda, Yoshinobu and Ennishi, Daisuke},
title = {Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117443},
doi = {10.1016/j.ejca.2026.117443}
}
EUVIMED